| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Wise John Drayton is a Chief Commercial Officer at INSMED Inc. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $13.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | INSM Insmed Inc | Chief Commercial Officer | Sell | 7,920 | $80.90 | $640,708.10 | -2.9% | -17.9% | +87.4% | |
| Jan 10, 2025 | INSM Insmed Inc | Chief Commercial Officer | Sale+OE | 13,587 | $65.95 | $896,074.08 | -2.7% | -0.7% | +169.7% | |
| May 28, 2024 | INSM Insmed Inc | Chief Commercial Officer | Sale+OE | 7,852 | $49.79 | $390,917.90 | -3.1% | +56.5% | +38.1% | |
| May 14, 2024 | INSM Insmed Inc | Chief Commercial Officer | Sell | 5,088 | $25.47 | $129,591.36 | -4.0% | +191.1% | +157.8% | |
| Jan 9, 2024 | INSM Insmed Inc | Chief Commercial Officer | Sell | 1,861 | $28.78 | $53,559.58 | -1.6% | -3.4% | +125.8% | |
| Jan 5, 2024 | INSM Insmed Inc | Chief Commercial Officer | Sale+OE | 21,238 | $29.20 | $620,088.93 | -8.8% | -7.1% | +138.0% | |
| May 25, 2023 | INSM Insmed Inc | Chief Commercial Officer | Sell | 3,366 | $18.95 | $63,785.70 | -3.2% | +18.1% | +17.6% | |
| May 17, 2023 | INSM Insmed Inc | Chief Commercial Officer | Sell | 2,887 | $18.44 | $53,223.82 | -0.9% | +21.3% | +35.2% | |
| Jan 10, 2023 | INSM Insmed Inc | Chief Commercial Officer | Sell | 779 | $17.96 | $13,990.84 | -1.0% | -11.3% | +49.8% | |
| Jan 5, 2023 | INSM Insmed Inc | Chief Commercial Officer | Sell | 1,160 | $19.74 | $22,898.40 | -1.6% | -16.7% | +48.7% |